Literature DB >> 32472377

Neurosurgeons and the fight with COVID-19: a position statement from the EANS Individual Membership Committee.

Mario Ganau1, David Netuka2, Marike Broekman3,4, Cesare Zoia5, Eleni Tsianaka6, Michael Schwake7, Naci Balak8, Amitendu Sekhar9, Sami Ridwan10, Hans Clusmann11.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32472377      PMCID: PMC7258601          DOI: 10.1007/s00701-020-04360-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


× No keyword cloud information.

Introduction

The growing SARS-CoV-2 pandemic is posing many new challenges to neurosurgeons, who have been forced to modify their working patterns by reducing/halting their elective theatres, triaging patients requiring emergency interventions, and helping out in other units such as emergency department and intensive care units. This outbreak is opening up entirely new scenarios; as such, concerns have been raised regarding the safety of patients and frontline healthcare professionals. To address these novel challenges, the following aspects are of particular importance to individual neurosurgeons: Lack of adequate information on SARS-Cov-2 and its disease (COVID-19) Ambiguity regarding appropriate personal protection equipment (PPE) Barriers to standard communication protocols Acute and chronic psychological distress Challenging the existing ethical fundaments The European Association of Neurosurgical Societies (EANS) has an Individual Membership Committee (IMC) whose main goal is to represent all EANS individual members from all over the world, ensuring that their voices are heard and their concerns are brought up to the various areas of the Society. This is done by constantly collecting individual members’ wishes and their daily challenges, making sure that they are heard at all levels; as such, the IMC gathers multiple times a year, either face to face or through virtual meetings. To try and support as many neurosurgeons as best as we can, the IMC decided to draft this position statement with the following purposes: (a) defend neurosurgeons’ right to seek and obtain adequate protection equipment, (b) highlight the need for constant update through online educational sources, and (c) favour neurosurgeons’ access to psychological support when needed. This statement was written by a task force created by IMC members; it references widely the latest evidence available in the international literature and leverages on the efforts already put in place by our Society through its website which is serving as a living platform for breaking news, discussing of hot topics and presenting agreement over best practices [2, 4, 12]. Finally, this statement covers the appropriate communication strategies to be implemented within neurosurgical teams at time of COVID-19 and outlines the need for a shared pan-European response to the crisis.

Access to adequate information and importance of qualitative research

The scientific literature on the impact of COVID-19 on neurosurgery is utterly fragmented, characterised by small reports with good regional representativeness, but limited external validity [13, 17]. European experience on clinical courses of COVID-19 in general has been published recently [3]. For this reason, collecting relevant neurosurgical data, outcome metrics and frontline information is essential. To overcome such lack of knowledge, the IMC decided to keep a close eye on the many surveys that have been released recently in order to assess how neurosurgeons all over the world are responding to the outbreak, how their professional and personal life has been affected, and last but not the least, how they are feeling in the midst of the potentially worst pandemic since over a century. The IMC has closely worked with authors of each survey (see Table 1) to facilitate their distribution among the international neurosurgical community and increase their statistical significance through high participation rate. Surveys could certainly fill unmet needs, such as the lack of granular data about the pandemic or the cultural and practical reasons behind different approaches adopted in different countries. It is therefore reasonable to expect relevant answers from this type of qualitative studies.
Table 1

Open surveys on the impact of COVID-19 on neurosurgery

Geographical outreach (language)Sponsor (website)Hyperlink
Worldwide (English)World Federation of Neurosurgical Societies – WFNS (https://www.wfns.org/)https://it.surveymonkey.com/r/VKW7NFR
USA/worldwide (English)Global BrainSurgery Initiative (https://www.gwmedicinehealth.com/departments/faculty/global-brainsurgery-initiative/)https://surveymonkey.com/r/J5ZDJ6D
Europe/worldwide (English)European Association of Neurosurgical Societies - EANS (https://www.eans.org)https://www.surveymonkey.de/r/PG8GYGS
Worldwide (English)AO Spine Foundation (https://aospine.foundation.org)https://aospine.aofoundation.org/about-ao-spine/news/2020/2020_03-covid-survey
Iberian Peninsula and Latin America (Spanish)Neurocirurgia Contemporánea (http://neurocirurgiacontemporanea.com)https://forms.gle/BcMa2YDUob7PRVMx7
UK (English)The Society of British Neurological Surgeons - SBNS, Neuro-Oncology Section (https://sbns.org.uk)To be released soon through SBNS website
Australia/worldwide (multiple languages)The Cochrane Collaborationhttps://sydneypublichealth.au1.qualtrics.com/jfe/form/SV_1AmgErWpIJVSAYd
Worldwide (multiple languages)Harvard, Oxford, Cambridge, Princeton, NYU, IESE, MIT, Boston and Warwick Universitieshttps://covid19-survey.org/
Open surveys on the impact of COVID-19 on neurosurgery

Personal protection equipment

One greatest source of concern, at present, is the lack of agreement on what PPE should be adopted and in which circumstances (e.g. daily ward rounds of neurosurgical patients admitted to COVID-19 wards, involvement in aerosol-generating procedures on COVID-19 positive patients and those suspected to be so, etc.). This issue has been constantly revised by the national and international public health authorities, with several updates which resulted in very different attitudes across different countries and sometimes even among regions. Such heterogeneity might depend on the highly variable number of cases isolated in each country, which simply represent the different stages of COVID-19 spreading across the world. Whereas we acknowledge that possible shortages can occur in the next weeks/months, hospitals should plan and enforce strategies to ensure the protection of their staff at any time without exceptions. The latest recommendations from the World Health Organization (WHO), consistent with the evidence from systematic reviews, highlight that adequate PPE should be used, depending on the level of exposure. To this extent, Level 2 PPE, consisting of masks (US N95, EU FFP2 or equivalent), long sleeved disposable gown, gloves and eye protection, should be worn whenever assisting with any procedure generating a moderate amount of fluid, spray and debris [15]. On the contrary, for all aerosol-generating procedures in COVID-19 positive patients, Level 3 PPE consisting of full-face respirators or FFP3 masks with visors, double gown, double gloves and rubber boots is recommended [15]. Depending on the neurosurgical intervention, a moderate to higher amount of aerosol can be generated by craniotome cutters, high-speed drills, bipolar/monopolar cautery, and even rinsing of the surgical site. As such, appropriate training before accessing surgical theatres is highly advisable: all masks should be fit-tested and not just fit-checked, and a risk assessment should be conducted by the entire team (surgeons, anaesthetists, scrub nurses and operating department practitioners) to select the needed PPE. This process is meant to ensure protection of the entire staff from both droplets (which are short lasting around the surgical site) and microdroplets (which, once generated, can last for over 30 min in the environment) [1]. On the other hand, Level 1 PPE consisting of surgical mask, plastic apron and non-sterile gloves should be considered whenever engaging on low-risk close patient contact clinical activities, such as ward rounds, physical examination and diagnostic imaging [15]. Since several members reported that testing is not always possible at the time of patient admission, or before carrying out a surgical procedures, especially in a time when emergencies are more common than non-deferrable elective interventions, neurosurgeons should have access to adequate PPE for all cases, at all times, without exception. There are some preliminary reports suggesting that (low-dose) native CT thorax imaging may increase the rate of early detection of COVID-19 in our patients; however, in asymptomatic patients, the irradiation exposure is a matter of discussion [10]. Until antibody testing will be widely available, or any other biotechnology/nanomedicine-based point-of-care device introduced for rapid and sensitive detection of SARS-Cov-2 [6, 14], the use of adequate PPE is the only feasible one to avoid accidental contamination due to late recognition of patients’ positive status, which could largely jeopardise the safety of entire surgical theatres and wards.

The importance of communication

COVID-19 crisis has got a severe impact on community hospitals and tertiary centres, their internal organisations, networks and referral systems. Several members suggested adopting a split teams ROTA (1 week on, 1 week off), so that teams never meet in person despite ensuring a continuity of care through virtual handovers, flexible on-calls and immediate support to those falling sick. In a time when interpersonal communication is changing rapidly, failures to exchange clinically relevant data, lack of completeness or simply defective information may lead to misunderstandings with severe patients’ safety fallouts. This may result in loss of trust and dismal team performances [5, 8]. We have all trained and operated in hospitals that relied on morning conferences, regular handovers, weekly multidisciplinary meetings, morbidity and mortality rounds, audit days, journal clubs, etc. just to abruptly see the backbone of our practice dismantled in few days. Digital health has been rapidly implemented with telemedicine consultations, virtual meetings, remote collection and analysis of clinical data. Although several authors had previously reported on the use of for example “Skype”, “Zoom”, “MS Teams” and many other tools in neurosurgery, we should immediately establish new standards of communication among our teams to ensure safe and secure transfer of the patients’ data without any breach of confidentiality [7, 11]. Similarly, the barriers in communication between neurosurgeons, patients and their families are also entirely new: COVID-19 positive patients are rapidly transferred to dedicated wards, and isolated from their loved ones, sometimes without even the opportunity to say them goodbye. Moreover, visitors and biomed company representatives are largely not allowed in hospitals at this time, creating additional barriers to the supply chain and limitations to the technical support needed by many healthcare professionals. Having to accept those dramatic situations and learning to keep our rational and professional attitude despite them have never been added to the healthcare algorithm before. It is very probable, that these difficulties will affect us from now on [16]. During the last few years, the hospitals that coped better with the aftermath of terror attacks in Europe are those that paid attention to providing immediate psychological support to their staff [9]. We therefore urge all our members that would feel it appropriate for safeguarding their well-being, and that of their staff, to seek psychological counselling and create the appropriate social safe-net within their hospital environment; we firmly believe that social distancing should never mean social isolation.

Learning on the field while dealing with physical and psychological stress

Neurosurgeons as any other healthcare workers in the epicentre of the COVID-19 crisis are asked to manage unexpected clinical scenarios and newly emerged situations without relevant experience or preparation. Different countries, cultures and societal structures are posing different challenges to our members. After drastic reduction/disappearance of slots for elective surgery, neurosurgeons are facing increased psychological stress, been involved in a difficult decision making process about triaging their patients and choosing which procedures should be postponed or cancelled. This stress partly results from a lack of generally accepted orientation and guidance. Many societies are working hard to provide the adequate ethical basis for such decisions. A generally accepted ethical fundament is extraordinarily important when it comes to decisions beyond our scope of “normality”, for example in catastrophic situations where regular medical (intensive as well as neurosurgical) care cannot be provided for all patients at need. Although it is as much difficult to adopt established working routines as envisioning what will be the state of the art in neurosurgery after this outbreak, neurosurgeons all over the world are called to explore unchartered territories while protecting the safety of their patients, themselves and their families. EANS committees like the ethico-legal committee can contribute in these challenging times, for example by communicating of and assisting in analyses of these strictly ethical challenges related to rationing and to taking risk without proper protection. EANS is taking a responsible lead in coordinating the activities of national neurosurgical societies through exchanging ideas, applying solutions and establishing supportive measures, including protocols, to relieve and help all the members, during this difficult period. For instance, a useful guide for triaging non-emergent neurosurgical procedures has been proposed, and warning letters regarding the higher risk of virus transmission during trans-sphenoidal approaches have been sent to all EANS members. To help members navigating through the many educational tools available, we have reviewed the current literature and secondary data sources (see Table 2). Getting through this challenging situation, EANS could potentially gain priceless experience by strengthening the links across the whole medical profession and scientific societies offering mutual collaboration and support.
Table 2

Educational resources on Neurosurgery and COVID-19 outbreak

SourceUpdatedLanguageHyperlink
General InformationGuidelines, recommendations, webinars, courses
  World Health Organisation - WHODailyMultiple translationshttps://www.who.int/emergencies/diseases/novel-coronavirus-2019
  European Society of Intensive Care Medicine - ESICMDailyEnglishhttps://www.esicm.org/resources/coronavirus-public-health-emergency/
  American Medical Association- AMADailyEnglishhttps://www.ama-assn.org/delivering-care/public-health/physicians-guide-covid-19
  American College of Surgeons - ACSDailyEnglishhttps://www.facs.org/covid-19
  Royal College of Surgeons of England - RCS EngWeeklyEnglishhttps://www.rcseng.ac.uk/coronavirus/
  Robert Koch InstitutDailyGerman and Englishhttps://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/nCoV.html
  Centers for Disease Control and Prevention - CDCDailyEnglishhttps://www.cdc.gov/coronavirus/2019-nCoV/index.html
High quality research papers
LancetDailyEnglishhttps://www.thelancet.com/coronavirus
JAMADailyEnglishhttps://jamanetwork.com/journals/jama/pages/coronavirus-alert
British Medical Journal - BMJDailyEnglishhttps://www.bmj.com/coronavirus
New England Journal of Medicine - NEJMDailyEnglishhttps://www.nejm.org/coronavirus?query=main_nav_lg
NatureDailyEnglishhttps://www.nature.com/
Neurosurgery Specific InformationRecommendations, policies, best practices
Congress of Neurological Surgeons – CNSDailyEnglishhttps://www.cns.org/covid-19
American Association of Neurological Surgeons – AANSDailyEnglishhttps://www.aans.org/COVID-19-Update/COVID-19-Information-Hub
European Association for Neurosurgical Societies - EANSWeeklyEnglishhttps://www.eans.org/page/Neuroscientific_aspects_of_Corona
Italian Society for Neurosurgery - SiNCHWeeklyItalianhttp://www.sinch.it/news/covid-and-neurosurgery-10
The Society of British Neurological Surgeons – SBNSWeeklyEnglishhttps://www.sbns.org.uk/index.php/policies-and-publications/covid/
Neuro-Anaesthesia and Critical Care Society - NACCSWeeklyEnglishhttps://naccs.org.uk/covid-19-resource-page/
Educational resources on Neurosurgery and COVID-19 outbreak

Limitations

This position statement is primarily intended to benefit neurosurgeons by sharing tailored information in a carefully written and timely delivered message; of note, it was conceived through a bottom-up approach, where members approached the IMC in search for opportunities to echoing their unmet needs. This aspect should be kept in the highest consideration by politicians, as well as healthcare professionals holding managerial positions. A series of limitations can be highlighted. With regard to surveys, although these tools are relatively inexpensive and powerful, we recognise the inherent limitations associated with such type of qualitative research. More specifically, at present, we do not possess access to the PICO research questions that have inspired each survey; we do not have any insights on the methodology used to calculate their sample size, nor the sampling strategy adopted to ensure statistical relevance. As such, we encourage neurosurgeons and journalists to be mindful of the possible sampling and interpretation biases that might affect the generalizability of those research tools. Furthermore, multiple factors, such as the lack of understanding of this virus, and the presence of a broad number of regulating healthcare bodies in Europe and the rest of the world, are limiting the possibility to compare and establish conclusions regarding the value of best practices. These represent significant obstacles to widely enforce protective measures, and might result in an underestimation of the threat. Finally, the lack of scientific evidence on many other aspects such as communication and psychological support at time of COVID-19 is currently limiting our ability to define recommendations and grade their strength. Last but not the least, there is some concern that scientific data on COVID-19 could be launched too fast so that its scientific reliability may be questioned in the future.

Conclusions

This outbreak of SARS-CoV-2 is certainly demonstrating that neurosurgeons should all prepare as teams, as well as individuals, to work under pressure with technical constraints that we could have never thought possible in modern times. To face the challenges that COVID-19 pandemic will bring upon us, and limit the related damages, we need to tackle its global perspective. Neurosurgeons are encouraged to contribute addressing the transnational dimension of this pandemic by providing feedbacks and experiences. In the coming weeks and months, among the many tasks that we skilfully perform daily, we should master the art of reacting as one system and not just as excellent local singularities. Neurosurgeons who still fight and suffer on their own should take the chance to join our community.
  13 in total

1.  WhatsAPP in neurosurgery: the best practice is in our hands.

Authors:  Francesca Graziano; R Maugeri; L Basile; C Guli; A Giugno; D G Iacopino
Journal:  Acta Neurochir (Wien)       Date:  2017-02-01       Impact factor: 2.216

2.  The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.

Authors:  Michael Dreher; Alexander Kersten; Johannes Bickenbach; Paul Balfanz; Bojan Hartmann; Christian Cornelissen; Ayham Daher; Robert Stöhr; Michael Kleines; Sebastian W Lemmen; Jörg Christian Brokmann; Tobias Müller; Dirk Müller-Wieland; Gernot Marx; Nikolaus Marx
Journal:  Dtsch Arztebl Int       Date:  2020-04-17       Impact factor: 5.594

3.  Understanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives.

Authors:  Laura Ganau; Lara Prisco; Gianfranco K I Ligarotti; Rossano Ambu; Mario Ganau
Journal:  Medicines (Basel)       Date:  2018-02-25

4.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Wai-Shing Leung; Anthony Raymond Tam; Tak-Chiu Wu; David Christopher Lung; Cyril Chik-Yan Yip; Jian-Piao Cai; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Chris Yau-Chung Choi; Lin-Lei Chen; Wan-Mui Chan; Kwok-Hung Chan; Jonathan Daniel Ip; Anthony Chin-Ki Ng; Rosana Wing-Shan Poon; Cui-Ting Luo; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Zhiwei Chen; Honglin Chen; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

5.  The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease 2019 (COVID-19) in January and February 2020 in China.

Authors:  Han Xiao; Yan Zhang; Desheng Kong; Shiyue Li; Ningxi Yang
Journal:  Med Sci Monit       Date:  2020-03-05

6.  Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

Authors:  Chunqin Long; Huaxiang Xu; Qinglin Shen; Xianghai Zhang; Bing Fan; Chuanhong Wang; Bingliang Zeng; Zicong Li; Xiaofen Li; Honglu Li
Journal:  Eur J Radiol       Date:  2020-03-25       Impact factor: 3.528

7.  What helps and hinders the provision of healthcare that minimises treatment burden and maximises patient capacity? A qualitative study of stroke health professional perspectives.

Authors:  John Kyle; Dimitris Skleparis; Frances S Mair; Katie I Gallacher
Journal:  BMJ Open       Date:  2020-03-18       Impact factor: 2.692

8.  Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection.

Authors:  Yu-Tang Tan; Jun-Wen Wang; Kai Zhao; Lin Han; Hua-Qiu Zhang; Hong-Quan Niu; Kai Shu; Ting Lei
Journal:  Curr Med Sci       Date:  2020-03-26

9.  Letter to the editor by Dobran Mauro, Paracino Riccardo, and Iacoangeli Maurizio regarding "Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy." Zoia C, Bongetta D, Veiceschi P, Cenzato M, Di Meco F, Locatelli D, Boeris D, Fontanella MM. Acta Neurochir (Wien). 2020 Mar 28. doi: 10.1007/s00701-020-04305-w.

Authors:  Mauro Dobran; Riccardo Paracino; Maurizio Iacoangeli
Journal:  Acta Neurochir (Wien)       Date:  2020-04-17       Impact factor: 2.216

Review 10.  Transmission and Control of Respiratory Viral Infections in the Healthcare Setting.

Authors:  Pablo E Bonvehí; Elena R Temporiti
Journal:  Curr Treat Options Infect Dis       Date:  2018-04-30
View more
  5 in total

1.  New adaptation of neurosurgical practice and residency programs during the Covid-19 pandemic and their effects on neurosurgery resident satisfaction and welfare at the National General Hospital, Jakarta, Indonesia.

Authors:  Setyo Widi Nugroho; Ivan Pradhana; Kevin Gunawan
Journal:  Heliyon       Date:  2021-08-12

2.  A simple mathematical tool to forecast COVID-19 cumulative case numbers.

Authors:  Naci Balak; Deniz Inan; Mario Ganau; Cesare Zoia; Sinan Sönmez; Batuhan Kurt; Ahmet Akgül; Müjgan Tez
Journal:  Clin Epidemiol Glob Health       Date:  2021-08-10

3.  Will the high acceptance rate of coronavirus disease 2019 vaccine in Morocco accelerate the recovery of neurosurgical practice?

Authors:  Farid Zahrou; Yassine Ait M'barek; Tarik Belokda; Badr Drai; Hasna Abdourafiq; Lamia Benantar; Khalid Aniba
Journal:  Surg Neurol Int       Date:  2021-09-30

4.  Letter to the Editor Regarding "Burnout Among Neurosurgeons and Residents in Neurosurgery: A Systematic Review and Meta-Analysis of the Literature".

Authors:  Laura Ganau; Gianfranco K I Ligarotti; Mario Ganau
Journal:  World Neurosurg       Date:  2022-09       Impact factor: 2.210

5.  A snapshot of European neurosurgery December 2019 vs. March 2020: just before and during the Covid-19 pandemic.

Authors:  T Mathiesen; M Arraez; T Asser; N Balak; S Barazi; C Bernucci; C Bolger; M L D Broekman; A K Demetriades; Z Feldman; M M Fontanella; N Foroglou; J Lafuente; A D Maier; B Meyer; M Niemelä; P H Roche; F Sala; N Samprón; U Sandvik; K Schaller; C Thome; M Thys; M Tisell; P Vajkoczy; M Visocchi
Journal:  Acta Neurochir (Wien)       Date:  2020-07-08       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.